[go: up one dir, main page]

FI934144L - Morfinanderivat och medicinsk anvaendning - Google Patents

Morfinanderivat och medicinsk anvaendning Download PDF

Info

Publication number
FI934144L
FI934144L FI934144A FI934144A FI934144L FI 934144 L FI934144 L FI 934144L FI 934144 A FI934144 A FI 934144A FI 934144 A FI934144 A FI 934144A FI 934144 L FI934144 L FI 934144L
Authority
FI
Finland
Prior art keywords
morfinanderivat
medicinsk
anvaendning
och
och medicinsk
Prior art date
Application number
FI934144A
Other languages
English (en)
Other versions
FI106126B (fi
FI934144A0 (fi
Inventor
Hiroshi Nagase
Koji Kawai
Kuniaki Kawamura
Jun Hayakawa
Takashi Endoh
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of FI934144A0 publication Critical patent/FI934144A0/fi
Publication of FI934144L publication Critical patent/FI934144L/fi
Application granted granted Critical
Publication of FI106126B publication Critical patent/FI106126B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Fertilizers (AREA)
  • Saccharide Compounds (AREA)
FI934144A 1992-01-23 1993-09-22 Menetelmä farmaseuttisten 6-typpisubstituoitujen 4,5-epoksimorfinaanijohdannaisten valmistamiseksi FI106126B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP1011592 1992-01-23
JP1011592 1992-01-23
JP29430892 1992-11-02
JP29430892 1992-11-02
PCT/JP1993/000080 WO1993015081A1 (en) 1992-01-23 1993-01-22 Morphinan derivative and medicinal use
JP9300080 1993-01-22

Publications (3)

Publication Number Publication Date
FI934144A0 FI934144A0 (fi) 1993-09-22
FI934144L true FI934144L (fi) 1993-09-22
FI106126B FI106126B (fi) 2000-11-30

Family

ID=26345314

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934144A FI106126B (fi) 1992-01-23 1993-09-22 Menetelmä farmaseuttisten 6-typpisubstituoitujen 4,5-epoksimorfinaanijohdannaisten valmistamiseksi

Country Status (15)

Country Link
US (2) US6323212B1 (fi)
EP (2) EP0846694A1 (fi)
JP (1) JP2525552B2 (fi)
KR (1) KR970011390B1 (fi)
AT (1) ATE172201T1 (fi)
AU (2) AU666702B2 (fi)
CA (1) CA2105072C (fi)
DE (1) DE69321525T2 (fi)
DK (1) DK0577847T3 (fi)
ES (1) ES2121988T3 (fi)
FI (1) FI106126B (fi)
NO (1) NO302755B1 (fi)
NZ (1) NZ246687A (fi)
TW (1) TW332814B (fi)
WO (1) WO1993015081A1 (fi)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323212B1 (en) * 1992-01-23 2001-11-27 Toray Industries, Inc. Morphinan derivative and its pharmaceutical applications
EP0657163B1 (en) * 1993-06-30 1998-10-14 Toray Industries, Inc. Antitussive
JP3948026B2 (ja) * 1993-07-19 2007-07-25 東レ株式会社 脳細胞保護剤
AU686203B2 (en) * 1993-07-23 1998-02-05 Toray Industries, Inc. Morphinan derivative and medicinal use
SE9401727D0 (sv) * 1994-05-18 1994-05-18 Astra Ab New compounds I
DE19602959A1 (de) * 1995-12-20 1997-07-31 Nycomed Arzneimittel Gmbh Neue Morphinderivate, Verfahren zu deren Herstellung und deren Verwendung
US5763445A (en) 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US6239154B1 (en) 1996-03-08 2001-05-29 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
EP0829481A1 (en) * 1996-09-16 1998-03-18 Pfizer Inc. Morphinan hydroxamic acid compounds
EP1310251A1 (en) * 1996-11-25 2003-05-14 Toray Industries, Inc. Antipruritic agent
ES2297882T3 (es) 1997-03-27 2008-05-01 Toray Industries, Inc. Derivados de morfinano y usos medicos de los mismos.
ES2217563T3 (es) * 1997-07-11 2004-11-01 Toray Industries, Inc. Compuestos medicinales estables que contienen derivados de 4,5-epoximorfinado.
CA2288828A1 (en) * 1997-07-14 1999-01-28 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
WO1999005146A1 (en) * 1997-07-25 1999-02-04 Toray Industries, Inc. Hyponatremia remedies
US6583151B2 (en) 1997-09-02 2003-06-24 Toray Industries, Inc. Remedies for drug addiction
US6083944A (en) * 1997-10-07 2000-07-04 Cephalon, Inc. Quinoline-containing α-ketoamide cysteine and serine protease inhibitors
TW570920B (en) * 1998-12-22 2004-01-11 Janssen Pharmaceutica Nv 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
WO2001014383A1 (en) * 1999-08-24 2001-03-01 Toray Industries, Inc. Remedies for neuropathic pain and model animals of neuropathic pain
WO2001039659A1 (en) * 1999-12-03 2001-06-07 Iouri Malov Field testing using spread spectrum technique
WO2001074819A1 (en) * 2000-04-03 2001-10-11 Toray Industries, Inc. Analgesics containing morphinan n-oxide derivatives as the active ingredient
JP4453254B2 (ja) 2001-03-30 2010-04-21 東レ株式会社 レストレス・レッグズ症候群治療薬
WO2002080918A1 (en) * 2001-04-02 2002-10-17 Toray Industries, Inc. Remedial or prophylactic agent for frequent urination or urinary incontinence
DE10161963A1 (de) * 2001-12-17 2003-07-03 Johannes Schuetz 6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung
US7923454B2 (en) * 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
WO2003097608A2 (en) 2002-05-17 2003-11-27 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7501433B2 (en) * 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
NZ539199A (en) 2002-10-09 2008-09-26 Toray Industries Remedies or preventives for urinary frequency or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7279579B2 (en) * 2003-06-04 2007-10-09 Alkermes, Inc. Polymorphic forms of naltrexone
ES2623362T3 (es) * 2004-05-28 2017-07-11 Human Biomolecular Research Institute Analgésicos metabólicamente estables y medicaciones para el dolor
AR053098A1 (es) * 2004-11-04 2007-04-25 Toray Industries Analgesico derivado de morfinano
AU2006234257B2 (en) * 2005-04-06 2011-03-10 Toray Industries, Inc. Crystals of morphinan derivative and process for producing the same
ES2307352B1 (es) * 2005-04-12 2009-09-18 Bti, I+D, S.L. Implante dental y piezas destinadas a ser conectadas a un implante dental, y la conexion interna entre el implante dental y cada pieza.
CN101466381B (zh) * 2006-04-21 2012-11-14 尼克塔治疗公司 吗啡酮的立体选择性还原
PL2151240T3 (pl) 2007-04-24 2014-01-31 Toray Industries Środek terapeutyczny lub profilaktyczny przeciw dyskinezie
ES2381056T3 (es) 2007-04-26 2012-05-22 Toray Industries, Inc. Preparación sólida estable que contiene un derivado de 4,5-epoximorfinano
ES2555785T3 (es) 2007-06-22 2016-01-08 Toray Industries, Inc. Remedio o preventivo para esquizofrenia
CA2702032C (en) 2007-10-05 2013-04-02 Shinji Ona Skin property-improving therapeutic agent comprising a morphinan derivative or any of its pharmacologically permissible acid addition salts as an active ingredient
JP2011512360A (ja) * 2008-02-14 2011-04-21 アルカーメス,インコーポレイテッド 選択的オピオイド化合物
US8609682B2 (en) 2008-07-11 2013-12-17 Regents Of The University Of Minnesota Analgesic agents
MX2011004307A (es) 2008-10-24 2011-07-28 Toray Industries Tableta estable conteniendo derivado de 4,5-epoximorfinano.
CN102325775A (zh) * 2009-02-23 2012-01-18 马林克罗特公司 (+)-6-羟基-吗啡喃或(+)-6-氨基-吗啡喃衍生物
EP2398806A1 (en) * 2009-02-23 2011-12-28 Mallinckrodt LLC (+)-morphinanium n-oxides and processes for their production
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
CN102325776A (zh) * 2009-02-23 2012-01-18 马林克罗特公司 (+)-吗啡喃*季盐及其制备方法
CN102459274B (zh) * 2009-06-11 2015-07-15 马林克罗特有限公司 6-酮基去甲吗啡喃通过催化氢转移的还原胺化
US8519133B2 (en) * 2009-06-11 2013-08-27 Mallinckrodt Llc Preparation of 6-alpha-amino N-substituted morphinans by catalytic hydrogen transfer
US8829020B2 (en) 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
US10363251B2 (en) 2009-07-16 2019-07-30 Mallinckrodt Llc (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
EP2529739B1 (en) 2010-01-29 2016-07-13 Toray Industries, Inc. Therapeutic or prophylactic agent for biliary diseases
WO2011154827A2 (en) 2010-06-11 2011-12-15 Rhodes Technologies Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
JP2013529595A (ja) 2010-06-11 2013-07-22 ローズ テクノロジーズ 第3級アミンのn−脱アルキル化方法
PL2593095T3 (pl) * 2010-07-16 2019-12-31 Mallinckrodt Llc (+)-morfinany jako antagoniści receptora toll-podobnego 9 i ich terapeutyczne zastosowania
WO2012054566A2 (en) 2010-10-19 2012-04-26 Memorial Sloan-Kettering Cancer Center 6-amido derivatives of 4,5a-epoxymorphinans for treatment of pain
CN103327977B (zh) 2011-01-31 2016-05-04 东丽株式会社 恶液质的治疗或预防剂
CN103717601A (zh) 2011-06-09 2014-04-09 马林克罗特有限公司 通过催化氢转移对6-酮基吗啡喃的还原胺化
PL2753622T3 (pl) 2011-09-08 2016-07-29 SpecGx LLC Wytwarzanie alkaloidów bez oddzielania związków pośrednich
DK2884978T3 (da) 2012-08-16 2019-09-30 Scripps Research Inst Nye Kappa-opioidligander
TWI449704B (zh) * 2013-04-26 2014-08-21 Everlight Chem Ind Corp 嗎啡喃衍生物之結晶、其製造方法、及使用其之醫藥組成物
WO2015082932A1 (en) 2013-12-05 2015-06-11 The University Of Bath Novel opioid compounds and their uses
JP2015166331A (ja) * 2014-05-14 2015-09-24 遼東化学工業株式会社 ナルフラフィンの結晶およびその製造方法
WO2016152953A1 (ja) * 2015-03-24 2016-09-29 東レ株式会社 モルヒナン誘導体及びその医薬用途
EP3291676B1 (en) 2015-04-30 2022-08-17 Memorial Sloan Kettering Cancer Center Mitragynine analogs and uses thereof
JP6885560B2 (ja) 2015-10-29 2021-06-16 国立大学法人 筑波大学 モルヒナン誘導体及びその医薬用途
US11529340B2 (en) 2016-03-22 2022-12-20 Regents Of The University Of Minnesota Combination for treating pain
US10988481B2 (en) * 2016-05-19 2021-04-27 Virginia Commonwealth University Potent and selective mu opioid receptor modulators
JP6814470B2 (ja) 2017-02-10 2021-01-20 国立大学法人 筑波大学 モルヒナン誘導体
EP3758701A1 (en) * 2018-02-27 2021-01-06 Delpor, Inc. Compositions for small molecule therapeutic agent compounds
AU2019229892B2 (en) 2018-03-08 2025-01-30 University Of Kansas Treatment of demyelinating diseases
CN113614089B (zh) * 2019-03-29 2024-08-20 人福医药美国公司 可用于治疗医学病症的新型吗啡喃
US11613547B2 (en) * 2019-07-08 2023-03-28 University Of Health Sciences & Pharmacy In St. Louis G-protein biased opioid receptor agonist/analgesics with reduced arrestin recruitment
KR20220071223A (ko) 2019-09-30 2022-05-31 닛뽕 케미파 가부시키가이샤 아제판 유도체
WO2021079978A1 (ja) 2019-10-24 2021-04-29 東レ株式会社 悪液質の治療剤又は予防剤
JP7735862B2 (ja) 2020-06-30 2025-09-09 東レ株式会社 代謝異常を伴う疾患又は症候群における筋力低下症状の改善剤又は予防剤
CN115181109B (zh) * 2021-04-02 2024-06-04 南京正大天晴制药有限公司 吗啡喃衍生物的晶体及其制备方法
TW202308627A (zh) 2021-04-23 2023-03-01 日商東麗股份有限公司 伴隨著飢餓素抗性之惡病體質的治療劑或預防劑
IL309232A (en) 2021-06-14 2024-02-01 Scorpion Therapeutics Inc Urea derivatives which can be used to treat cancer
CN115960108B (zh) * 2021-10-09 2026-02-03 山东新时代药业有限公司 一种无定型盐酸纳呋拉啡及其制备方法
JPWO2023190665A1 (fi) * 2022-03-29 2023-10-05

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL290054A (fi)
US3236851A (en) * 1966-02-22 Unsaturated morphinan derivatives
DE622231C (de) * 1934-03-09 1935-11-23 Hermann Fischer Dr Verfahren zur Herstellung von Diacetylmorphin
GB864107A (en) 1958-09-10 1961-03-29 Albert Boehringer Morphine derivatives
GB919311A (en) 1958-10-29 1963-02-20 T & H Smith Ltd Derivatives of 14-hydroxycodeine and their preparation
DE2254298A1 (de) 1972-11-06 1974-05-16 Boehringer Sohn Ingelheim Neue (heteroarylmethyl)-normorphine, deren saeureadditionssalze, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
GB1593191A (en) * 1977-03-23 1981-07-15 Reckitt & Colmann Prod Ltd Derivatives of morphine
GB1587831A (en) * 1977-03-23 1981-04-08 Reckitt & Colmann Prod Ltd Morphine derivatives
US4362870A (en) 1980-01-16 1982-12-07 Regents Of The University Of Minnesota Selective opioid receptor alkylating agents
JPS574991A (en) * 1980-06-10 1982-01-11 Sankyo Co Ltd Cyclopropylmethylnormorphine-6-sulfuric ester
US4401672A (en) 1981-10-13 1983-08-30 Regents Of The University Of Minnesota Non-addictive narcotic antitussive preparation
US4668685A (en) * 1984-07-05 1987-05-26 E.I. Du Pont De Nemours And Company Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
US4767718A (en) * 1984-06-18 1988-08-30 Southern Illinois University Foundation Fluorescent opioid reagents and methods of use thereof in the detection of opioid receptors
IN163125B (fi) * 1985-01-08 1988-08-13 Alkaloida Vegyeszeti Gyar
HU196376B (en) * 1985-05-23 1988-11-28 Sandoz Ag Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds
DE3617182A1 (de) 1985-05-23 1986-11-27 Sandoz-Patent-GmbH, 79539 Lörrach Morphinan-derivate
US4730048A (en) 1985-12-12 1988-03-08 Regents Of The University Of Minnesota Gut-selective opiates
US4806556A (en) 1985-12-12 1989-02-21 Regents Of The University Of Minnesota Gut-selective opiates
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US4816586A (en) * 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
JPH01149788A (ja) * 1987-12-08 1989-06-12 Chugai Pharmaceut Co Ltd 新規なモルヒネ誘導体
FR2636330B1 (fr) 1988-09-13 1990-11-30 Sanofi Sa Procede de preparation de derives de morphinane
CA2006311A1 (en) 1988-12-21 1990-06-21 Ken Kanematsu Morphine derivative
US5219861A (en) * 1988-12-21 1993-06-15 Chugai Seiyaku Kabushiki Kaisha 6 β-Thiomorphine derivatives
US5258386A (en) * 1991-06-05 1993-11-02 The United States Of America As Represented By The Secretary Of The Army (+)-3-substituted-N alkylmorphinans, synthesis and use as anticonvulsant and neuroprotective agents
US6323212B1 (en) * 1992-01-23 2001-11-27 Toray Industries, Inc. Morphinan derivative and its pharmaceutical applications
EP0657163B1 (en) * 1993-06-30 1998-10-14 Toray Industries, Inc. Antitussive

Also Published As

Publication number Publication date
EP0577847A1 (en) 1994-01-12
ATE172201T1 (de) 1998-10-15
ES2121988T3 (es) 1998-12-16
EP0577847B1 (en) 1998-10-14
TW332814B (en) 1998-06-01
EP0577847A4 (en) 1994-12-07
NO933376D0 (no) 1993-09-22
NZ246687A (en) 1996-12-20
FI106126B (fi) 2000-11-30
WO1993015081A1 (en) 1993-08-05
KR970011390B1 (ko) 1997-07-10
DE69321525D1 (de) 1998-11-19
JP2525552B2 (ja) 1996-08-21
FI934144A0 (fi) 1993-09-22
DE69321525T2 (de) 1999-03-04
JPH08502275A (ja) 1996-03-12
AU666702B2 (en) 1996-02-22
NO302755B1 (no) 1998-04-20
DK0577847T3 (da) 1999-06-23
US6323212B1 (en) 2001-11-27
CA2105072A1 (en) 1993-07-24
AU3367193A (en) 1993-09-01
EP0846694A1 (en) 1998-06-10
NO933376L (no) 1993-09-23
CA2105072C (en) 1998-07-28
US6277859B1 (en) 2001-08-21
AU686483B2 (en) 1998-02-05
AU4067195A (en) 1996-03-07

Similar Documents

Publication Publication Date Title
FI931458A7 (fi) Pyrimidinderivat och foerfarande foer deras framstaellning
FI934144L (fi) Morfinanderivat och medicinsk anvaendning
FI930605L (fi) Cd40cr-receptor och ligander foer denna
FI930064A0 (fi) Anpassningsbar ekvalisator och mottagare
FI931183A0 (fi) Halvledarkondensator och mikrofonanordning
FI930459L (fi) Schampokompositioner och suspenderingsmedel foer dessa
FI933106L (fi) Miljoevaenliga vattenbaserade nyanseringskoncentrat foer maolfaerger och dylikt
FI935239A0 (fi) Foerfarande och anordning foer kakframstaellning
FI934243A7 (fi) Vaermeisolerande stoed foer betongvaegg och betongvaegg anvaendande detsamma
FI931085A0 (fi) Antitumoerkompositioner och behandlingsmetoder
FI924060A7 (fi) Cellulaert radionaet och mobilradiostation
FI931675A7 (fi) Vaordshampookomposition och foerfarande foer framstaellning och anvaendningav densamma
FI933194L (fi) Verktyg och verktygshaollare foer handverktygsanordning
FI930076L (fi) Cysteamin innehaollande permanentningskomposition och foerfarande
FI930831A7 (fi) Kelatkomplex och foerfarande foer deras framstaellning
FI930457L (fi) Stabilt vaordschampo innehaollande katjoniska och suspenderade vattenoloesliga vaordmedel
FI922004L (fi) Maetningsfoerfarande och maetanordning
FI930777A7 (fi) Foeraedling och foerfarande foer avfallspapper
FI930104A7 (fi) Verktyg foer slagborrning och meissling och verktygshaollare foer saodana verktyg
FI932992L (fi) Fungisida fenylbenzamider och foerfaranden foer framstaellning daerav
FI934856A0 (fi) Bandkassett och automatisk anordning foer vaermefogbara bandstycken
FI934747L (fi) a-fosfonosulfonatskvalensyntetas-inhibitorer och foerfarande
FI930453L (fi) Tumoerhaemmande kompositioner och behandlingsmetoder
FI931346L (fi) Butadienderivat och foerfarande foer deras framstaellning
FI932801L (fi) Polyolefinfyllmedelkompositmaterialier och deras anvaendning

Legal Events

Date Code Title Description
MA Patent expired